- Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Mengjiao Zhou et al, 2022, Frontiers in Pharmacology CrossRef - Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
Sosmitha Girisa et al, 2021, Molecular Biomedicine CrossRef - miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation
Mohamed Salem et al, 2019, International Journal of Molecular Sciences CrossRef